IL-17 Monoclonal Antibodies

589 IL-17 monoclonal antibodies from 25 antibody suppliers Click each IL-17 monoclonal antibody that interests you to view the full IL-17 monoclonal antibody datasheet.

Flow Cytometry - Use Filter to switch application

Supplier data
Boster Biological Technology M00421

IL-17 antibody, M00421, Boster Biological Technology. Monoclonal anti IL-17A was used to detect IL17A and separate Mouse CD4+ Cells by flow cytometry. Mouse CD4+ T cells were isolated from freshly dissected spleen by centrifugation in T cell separation media and selected by magnetic separation. Cells were grown on plates coated with anti-CD3 antibody, and stimulated with: 5 μg/mL anti-CD28, 10 ng/mL IL-1beta, 50 ng/mL mouse IL-6, 1 ng/mL TGFbeta1 and 10 μg/mL anti-mouse IFN over 8-10 days of culture. Cells were incubated for 15-20 minutes with Add

Rat Mono [20B4.G10.F5 IgG2a kappa], 100 ul
Mo
FACS, IHC-F, IHC-P, WB

IHC-F, IHC-P, IL-17 antibody, M00421, Boster Biological Technology, Western Blot image

Supplier data
Origene AM31212FC-N IL-17 antibody, AM31212FC-N, Origene.

Mouse Mono [Clone B-A50], 1 ml
Hu
FACS

Supplier data
Origene AM31212RP-N IL-17 antibody, AM31212RP-N, Origene.

Mouse Mono [Clone B-A50], 1 ml
Hu
FACS

Supplier data
Origene AM31212PU-N IL-17 antibody, AM31212PU-N, Origene.

Mouse Mono [Clone B-A50], 2 ml
Hu
FACS

Supplier data
Proteintech Group 66148-1-Ig IL-17 antibody, 66148-1-Ig, Proteintech Group. The IL-17 antibody from Proteintech is a mouse monoclonal antibody to a fusion protein of human IL-17. This antibody recognizes human antigen. The IL-17 antibody has been validated for the following applications: FC, WB, ELISA analysis.

IL-17 antibody, 66148-1-Ig, Proteintech Group. The IL-17 antibody from Proteintech is a mouse monoclonal antibody to a fusion protein of human IL-17. This antibody recognizes human antigen. The IL-17 antibody has been validated for the following applications: FC, WB, ELISA analysis.

Mouse Mono [66148-1-Ig], 150 ul
Hu
ELISA, FACS, WB

ELISA,

IL-17 antibody, 66148-1-Ig, Proteintech Group, Western Blot image

Supplier data
Novus Biologicals NBP2-27338

IL-17 antibody, NBP2-27338, Novus Biologicals. Flow Cytometry: IL-17/IL-17A Antibody (4H1524) [NBP2-27338] - Analysis using the PE conjugate of NBP2-25229. IL-17A positive cells in PMA/IM stimulated fresh PBMC: PBMC stimulated for 6h with PMA (25ng/ml) & IM (250ng/ml), in the presence of BFA. Cells were surface stained with CD4 APC, fixed & permeabilised for intracellular staining with PE conjugated

Mouse Mono [4H1524], 100 ug
Hu
Bl, ELISA, FACS, WB

IL-17 antibody, NBP2-27338, Novus Biologicals, Blocking image

Bl,

IL-17 antibody, NBP2-27338, Novus Biologicals, Enzyme Linked Immunosorbent Assay image

ELISA,

IL-17 antibody, NBP2-27338, Novus Biologicals, Western Blot image

Supplier data
Novus Biologicals NBP2-25229

IL-17 antibody, NBP2-25229, Novus Biologicals. Flow Cytometry: IL-17/IL-17A Antibody (4H1524) - Azide Free [NBP2-25229] - Analysis using the PE conjugate of NBP2-25229. IL-17A positive cells in PMA/IM stimulated fresh PBMC: PBMC stimulated for 6h with PMA (25ng/ml) & IM (250ng/ml), in the presence of BFA. Cells were surface stained with CD4 APC, fixed & permeabilised for intracellular staining with PE conjugated

Mouse Mono [4H1524], 250 ng
Hu
ELISA, FACS, IHC-F, WB

IL-17 antibody, NBP2-25229, Novus Biologicals, Enzyme Linked Immunosorbent Assay image

ELISA, IHC-F, IL-17 antibody, NBP2-25229, Novus Biologicals, Western Blot image

Supplier data
Novus Biologicals DDX0336P-100 IL-17 antibody, DDX0336P-100, Novus Biologicals. Flow Cytometry: IL-17/IL-17A Antibody (408H6.01/mAb25) [DDX0336P-100]

IL-17 antibody, DDX0336P-100, Novus Biologicals. Flow Cytometry: IL-17/IL-17A Antibody (408H6.01/mAb25) [DDX0336P-100]

Mouse Mono [408H6.01/mAb25], 100 ug
Hu, Mo
ELISA, FACS, WB

ELISA,

IL-17 antibody, DDX0336P-100, Novus Biologicals, Western Blot image

Supplier data
Novus Biologicals NBP2-27252

IL-17 antibody, NBP2-27252, Novus Biologicals. Flow Cytometry: IL17 Antibody (4H1524) [PE] [NBP2-27252] - IL-17A positive cells in PMA/IM stimulated fresh PBMC: PBMC stimulated for 6h with PMA (25ng/ml) & IM (250ng/ml), in the presence of BFA. Cells were surface stained with CD4 APC, fixed & permeabilised for intracellular staining with PE conjugated IL-17A antibody (clone: 4H1524) or isotype control. Data shown includes simultaneously stained un-stimulated (Left panel) & stimulated (PMA/IM; Right panel) cells. Serum blocking to reduce backg

Mouse Mono [4H1524], 100 Test
Hu
FACS

Supplier data
Lifespan Biosciences LS-C37030 IL-17 antibody, LS-C37030, Lifespan Biosciences. Untreated (A) and PMA/ionomycin -stimulated (B) human PBMCs were stained using PE-conjugated mouse anti-human CD3 antibody and APC-conjugated antibody Interleukin 17 (IL-17, CTLA8, IL-17A, Interleukin-17A precursor, Cytotoxic T-lymphocyte-associated ...

IL-17 antibody, LS-C37030, Lifespan Biosciences. Untreated (A) and PMA/ionomycin -stimulated (B) human PBMCs were stained using PE-conjugated mouse anti-human CD3 antibody and APC-conjugated antibody Interleukin 17 (IL-17, CTLA8, IL-17A, Interleukin-17A precursor, Cytotoxic T-lymphocyte-associated ...

Mouse Mono [LS-C37030], 100 Test
Hu
FACS

Supplier data
R&D Systems MAB7211 IL-17 antibody, MAB7211, R&D Systems. Detection of IL-17/IL-17A in Mouse Splenocytes Stimulated to Induce Th17 cells by Flow Cytometry.

IL-17 antibody, MAB7211, R&D Systems. Detection of IL-17/IL-17A in Mouse Splenocytes Stimulated to Induce Th17 cells by Flow Cytometry.

Rat Mono [881309], 100 ug
Mo
AP, FACS

Supplier data
R&D Systems IC317N IL-17 antibody, IC317N, R&D Systems. Detection of IL-17/IL-17A in Human PBMCs by Flow Cytometry.

Mouse Mono [41809], 100 Test
Hu
FACS

Supplier data
R&D Systems IC317G IL-17 antibody, IC317G, R&D Systems. Detection of IL-17/IL-17A in Human PBMCs by Flow Cytometry.

Mouse Mono [41809], 100 Test
Hu
FACS

Supplier data
R&D Systems IC317A IL-17 antibody, IC317A, R&D Systems. Detection of IL-17/IL-17A in Human PBMCs by Flow Cytometry.

Mouse Mono [41809], 100 Test
Hu
FACS

Supplier data
R&D Systems IC317P IL-17 antibody, IC317P, R&D Systems. <P align=left>Detection of IL-17/IL-17A in Th17-differentiated Human CD4<SUP>+</SUP> PBMCs by Flow Cytometry.

IL-17 antibody, IC317P, R&D Systems. <P align=left>Detection of IL-17/IL-17A in Th17-differentiated Human CD4<SUP>+</SUP> PBMCs by Flow Cytometry.

Mouse Mono [41809], 100 Test
Hu
FACS

(1)

1 review

Supplier data
BioLegend 506928 IL-17 antibody, 506928, BioLegend. PMA + ionomycin–stimulated (six hours) mouse thymoma cell line EL-4 (in the presence of monensin) was intracellularly stained with IL-17 (clone TC11-18H10.1) Brilliant Violet 785™ (filled histogram) or rat IgG1, κ Brilliant Violet 785™ isotype control (open histogram).

IL-17 antibody, 506928, BioLegend. PMA + ionomycin–stimulated (six hours) mouse thymoma cell line EL-4 (in the presence of monensin) was intracellularly stained with IL-17 (clone TC11-18H10.1) Brilliant Violet 785™ (filled histogram) or rat IgG1, κ Brilliant Violet 785™ isotype control (open histogram).

Rat Mono [TC11-18H10.1], 50 ug
Mo
FACS

Supplier data
BioLegend 512337 IL-17 antibody, 512337, BioLegend. Human peripheral blood lymphocytes were stimulated with PMA + Ionomycin for 6 hours (in the presence of monensin), stained with CD3 FITC, fixed, permeabilized, and then stained with IL-17A (clone BL168) Brilliant Violet 785™ (top) or mouse IgG1, κ Brilliant Violet 785™ isotype control (bottom).

IL-17 antibody, 512337, BioLegend. Human peripheral blood lymphocytes were stimulated with PMA + Ionomycin for 6 hours (in the presence of monensin), stained with CD3 FITC, fixed, permeabilized, and then stained with IL-17A (clone BL168) Brilliant Violet 785™ (top) or mouse IgG1, κ Brilliant Violet 785™ isotype control (bottom).

Mouse Mono [BL168], 25 Test
Hu
FACS

Supplier data
BioLegend 512338 IL-17 antibody, 512338, BioLegend. Human peripheral blood lymphocytes were stimulated with PMA + Ionomycin for 6 hours (in the presence of monensin), stained with CD3 FITC, fixed, permeabilized, and then stained with IL-17A (clone BL168) Brilliant Violet 785™ (top) or mouse IgG1, κ Brilliant Violet 785™ isotype control (bottom).

IL-17 antibody, 512338, BioLegend. Human peripheral blood lymphocytes were stimulated with PMA + Ionomycin for 6 hours (in the presence of monensin), stained with CD3 FITC, fixed, permeabilized, and then stained with IL-17A (clone BL168) Brilliant Violet 785™ (top) or mouse IgG1, κ Brilliant Violet 785™ isotype control (bottom).

Mouse Mono [BL168], 100 Test
Hu
FACS

Supplier data
BioLegend 506930 IL-17 antibody, 506930, BioLegend. Th17-polarized C57BL/6 mouse CD4+ lymphocytes were stimulated with PMA + Ionomycin for 6 hours (in the presence of monensin), stained with CD4 FITC, fixed, permeabilized, and then stained with IL-17A (clone TC11-18H10.1) Brilliant Violet 650™.

IL-17 antibody, 506930, BioLegend. Th17-polarized C57BL/6 mouse CD4+ lymphocytes were stimulated with PMA + Ionomycin for 6 hours (in the presence of monensin), stained with CD4 FITC, fixed, permeabilized, and then stained with IL-17A (clone TC11-18H10.1) Brilliant Violet 650™.

Rat Mono [TC11-18H10.1], 50 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 69-7177-82

IL-17 antibody, 69-7177-82, Invitrogen Antibodies. Th17-polarized mouse splenocytes were unstimulated (left) or stimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) (right) and then intracellularly stained with Anti-Mouse CD4 APC (Product # 17-0042-82) and 0.25 µg of Anti-Mouse/Rat IL-17A eFluor® 506, using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Viable cells, as determined by Fixable Viability Dye eFluor® 780 (Product # 65-

Rat Mono [eBio17B7], 100 ug
Mo, Rt
FACS

Supplier data
Invitrogen Antibodies 17-7179-42

IL-17 antibody, 17-7179-42, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 10 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail plus protein transport inhibitors (Product # 00-4975-03) (right) for 6 hours. Cells were intracellularly stained with Anti-Human CD4 FITC (Product # 11-0047-42) and Anti-Human IL-17A APC using the Intracellular Fixation &

Mouse Mono [eBio64DEC17], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 48-7179-42

IL-17 antibody, 48-7179-42, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 6 days. Cells were restimulated with the Cell Stimulation Cocktail plus protein transport inhibitors (Product # 00-4975-03) for 5 hours and then intracellularly stained with Anti-Human CD4 PE (Product # 12-0049-42) and Mouse IgG1 K Isotype Control eFluor® 450 (Product # 12-4714-81) (left) or Anti-Human IL-17A eFluor® 450 (right) using the Intrace

Mouse Mono [eBio64DEC17], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 17-7179-41

IL-17 antibody, 17-7179-41, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 10 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail plus protein transport inhibitors (Product # 00-4975-03) (right) for 6 hours. Cells were intracellularly stained with Anti-Human CD4 FITC (Product # 11-0047-42) and Anti-Human IL-17A APC using the Intracellular Fixation &

Mouse Mono [eBio64DEC17], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 50-7178-41

IL-17 antibody, 50-7178-41, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 8 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 6 hours. Cells were stained with Fixable Viability Dye eFluor® 780 (Product # 65-0865-14) followed by intracellular staining with Anti-Human CD4 PE

Mouse Mono [eBio64CAP17], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 53-7172-80

IL-17 antibody, 53-7172-80, Invitrogen Antibodies. Intracellular staining of CD4+CD25- T cells purified from C57BL/6 mouse splenocytes cultured with 10-day DCs in the presence of Anti-Mouse CD3 Functional Grade Purified (Product # 16-0031-82), Mouse IL-4, IL-6 and TGF beta Recombinant Proteins for 4 days. Cells were restimulated with PMA/Ionomycin in the presence of monensin for 5 hrs, then fixed, permeabilized, and stained with 0.2

Rat Mono [eBioTC11-18H10.1], 25 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 50-7178-42

IL-17 antibody, 50-7178-42, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 8 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 6 hours. Cells were stained with Fixable Viability Dye eFluor® 780 (Product # 65-0865-14) followed by intracellular staining with Anti-Human CD4 PE

Mouse Mono [eBio64CAP17], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 69-7179-42

IL-17 antibody, 69-7179-42, Invitrogen Antibodies. Normal human peripheral blood cells stimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 5 hours. Cells were intracellularly stained with Anti-Human CD4 PE (Product # 12-0047-42) and Anti-Human IL-17A eFluor® 506, using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Cells in the lymphocyte gate were used for analysis.

Mouse Mono [eBio64DEC17], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 45-7177-82

IL-17 antibody, 45-7177-82, Invitrogen Antibodies. Intracellular staining of 3-day Th17-polarized splenocytes treated with Brefeldin A (left) or restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) (right) with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.015 µg of Anti-Mouse/Rat IL-17A PerCP-Cyanine5-5 using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Cells in the lymphocyte gate were used for analysis.

Rat Mono [eBio17B7], 100 ug
Mo, Rt
FACS

Supplier data
Invitrogen Antibodies 48-7177-80

IL-17 antibody, 48-7177-80, Invitrogen Antibodies. Intracellular staining of 10-day Th17-polarized mouse splenocytes stimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.125 µg of Rat IgG2a K Isotype Control (Product # 48-4321-82) (left) or 0.125 µg of Anti-Mouse/Rat IL-17A eFluor® 450 (right) using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Viable cells, as determined by

Rat Mono [eBio17B7], 25 ug
Mo, Rt
FACS

Supplier data
Invitrogen Antibodies 45-7177-80

IL-17 antibody, 45-7177-80, Invitrogen Antibodies. Intracellular staining of 3-day Th17-polarized splenocytes treated with Brefeldin A (left) or restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) (right) with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.015 µg of Anti-Mouse/Rat IL-17A PerCP-Cyanine5-5 using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Cells in the lymphocyte gate were used for analysis.

Rat Mono [eBio17B7], 25 ug
Mo, Rt
FACS

Supplier data
Invitrogen Antibodies 12-7179-42

IL-17 antibody, 12-7179-42, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 10 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 6 hours. Cells were intracellular stained with Anti-Human CD4 APC (Product # 17-0049-42) and Anti-Human IL-17A FITC using the Fixation & Permeabilizati

Mouse Mono [eBio64DEC17], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 25-7179-41

IL-17 antibody, 25-7179-41, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 10 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 6 hours. Cells were intracellularly stained with Anti-Human CD4 APC (Product # 17-0049-42) and Anti-Human IL-17A PE-Cyanine7 using the Fixation & Perme

Mouse Mono [eBio64DEC17], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 50-7179-42

IL-17 antibody, 50-7179-42, Invitrogen Antibodies. Intracellular staining of normal human peripheral blood cells stimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) for 5 hours with Anti-Human CD3 FITC (Product # 11-0037-42) and Mouse IgG1 K Isotype Control eFluor® 660 (Product # 50-4714-82) (left) or Anti-Human IL-17A eFluor® 660 (right). Cells were fixed and permeabilized using Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00). Cells in the lymphocyte gat

Mouse Mono [eBio64DEC17], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 47-7179-42

IL-17 antibody, 47-7179-42, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 10 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail plus protein transport inhibitors (Product # 00-4975-03) (right) for 6 hours. Cells were stained intracellularly with Anti-Human CD4 FITC (Product # 11-0047-42) and Anti-Human IL-17A APC-eFluor® 780 using the Intracell

Mouse Mono [eBio64DEC17], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 25-7177-82

IL-17 antibody, 25-7177-82, Invitrogen Antibodies. Intracellular staining of 10-day Th17-polarized mouse splenocytes either unstimulated (left) or stimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) (right) with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.25 µg of Anti-Mouse/Rat IL-17A PE-Cyanine7 using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol.

Rat Mono [eBio17B7], 100 ug
Mo, Rt
FACS

Supplier data
Invitrogen Antibodies 53-7179-41

IL-17 antibody, 53-7179-41, Invitrogen Antibodies. Intracellular staining of normal human peripheral blood cells stimulated overnight with PMA/Ionomycin in the presence of monensin with Anti-Human CD3 APC (Product # 17-0038-42) and Mouse IgG1 K Isotype Control Alexa Fluor® 488 (Product # 53-4714-42) (left) or Anti-Human IL-17A Alexa Fluor® 488 (right) using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00). Cells in the lymphocyte gate were used for analysis.

Mouse Mono [eBio64DEC17], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 45-7179-41

IL-17 antibody, 45-7179-41, Invitrogen Antibodies. Intracellular staining of normal human peripheral blood cells stimulated with PMA/Ionomycin for 5 hours in the presence of Monensin with Anti-Human CD3 FITC (Product # 11-0039-42) and Mouse IgG1 K Isotype Control PerCP-Cyanine5-5 (Product # 45-4714-82) (left) or Anti-Human IL-17A PerCP-Cyanine5-5 (right). Cells in the lymphocyte gate were used for analysis.

Mouse Mono [eBio64DEC17], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 69-7177-80

IL-17 antibody, 69-7177-80, Invitrogen Antibodies. Th17-polarized mouse splenocytes were unstimulated (left) or stimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) (right) and then intracellularly stained with Anti-Mouse CD4 APC (Product # 17-0042-82) and 0.25 µg of Anti-Mouse/Rat IL-17A eFluor® 506, using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Viable cells, as determined by Fixable Viability Dye eFluor® 780 (Product # 65-

Rat Mono [eBio17B7], 25 ug
Mo, Rt
FACS

Supplier data
Invitrogen Antibodies 11-7177-80

IL-17 antibody, 11-7177-80, Invitrogen Antibodies. Splenocytes were cultured under Th17-polarizing conditions for 6 days and then restimulated with the Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) for 5 hours. Cells were intracellularly stained with Anti-Mouse CD4 PerCP-eFluor® 710 (Product # 46-0042-82) and 0.125 µg of Rat IgG2a K Isotype Control FITC (Product # 11-4321-42) (left) or 0.125 µg of Anti-Mouse/Rat IL-17A FITC (right) using the Intracellular Fixation & Permeabilization Buffer S

Rat Mono [eBio17B7], 25 ug
Mo, Rt
FACS, IHC-P

IHC-P

Supplier data
Invitrogen Antibodies 11-7179-42

IL-17 antibody, 11-7179-42, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 10 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 6 hours. Cells were stained Anti-Human CD4 PE (Product # 12-0047-42) and Anti-Human IL-17A FITC using the Fixation & Permeabilization Buffers (Product

Mouse Mono [eBio64DEC17], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 17-7177-81

IL-17 antibody, 17-7177-81, Invitrogen Antibodies. Intracellular staining of 10 day-Th17 polarized mouse splenocytes either unstimulated in the presence of Brefeldin A (left) or stimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975) (right) with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.06 µg of Anti-Mouse/Rat IL-17A APC using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol.

Rat Mono [eBio17B7], 50 ug
Mo, Rt
FACS

Supplier data
Invitrogen Antibodies 50-7177-82

IL-17 antibody, 50-7177-82, Invitrogen Antibodies. Mouse splenocytes were cultured for 7 days under Th17-polarization conditions. Cells were unstimulated (left) or stimulated (right) with Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) and intracellularly stained with Anti-Mouse CD4 FITC (Product # 11-0041-82) and 0.125 µg of Anti-Mouse/Rat IL-17A eFluor® 660 using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Viable cells, as determined by Fixable Via

Rat Mono [eBio17B7], 100 ug
Mo, Rt
FACS, IHC-P

IHC-P

Supplier data
Invitrogen Antibodies 61-7177-82

IL-17 antibody, 61-7177-82, Invitrogen Antibodies. Splenocytes were cultured under Th17-polarizing conditions for 6 days then restimulated for 5 hours with the Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03). Cells were intracellularly stained with Anti-Mouse CD4 PerCP-eFluor® 710 (Product # 46-0042-82) and 0.125 µg of Rat IgG2a K Isotype Control PE-eFluor® 610 (Product # 61-4321-82) (left) or 0.125 µg of Anti-Mouse/Rat IL-17A PE-eFluor® 610 (right) using the Intracellular Fixation & P

Rat Mono [eBio17B7], 100 ug
Mo, Rt
FACS

Supplier data
Invitrogen Antibodies 61-7177-80

IL-17 antibody, 61-7177-80, Invitrogen Antibodies. Splenocytes were cultured under Th17-polarizing conditions for 6 days then restimulated for 5 hours with the Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03). Cells were intracellularly stained with Anti-Mouse CD4 PerCP-eFluor® 710 (Product # 46-0042-82) and 0.125 µg of Rat IgG2a K Isotype Control PE-eFluor® 610 (Product # 61-4321-82) (left) or 0.125 µg of Anti-Mouse/Rat IL-17A PE-eFluor® 610 (right) using the Intracellular Fixation & P

Rat Mono [eBio17B7], 25 ug
Mo, Rt
FACS

Supplier data
Invitrogen Antibodies 53-7177-81

IL-17 antibody, 53-7177-81, Invitrogen Antibodies. Intracellular staining of splenocytes cultured under Th17-polarizing conditions followed by reactivation with PCell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) for 5 hours with 0.25 µg of Rat IgG2a K Isotype Control APC (Product # 17-4321-81) (left) or 0.25 µg of Anti-Mouse/Rat IL-17A Alexa Fluor® 488 (right) using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Cells in the lymphocyte gate w

Rat Mono [eBio17B7], 50 ug
Mo, Rt
FACS, IHC-P

IHC-P

Supplier data
Invitrogen Antibodies 53-7179-42

IL-17 antibody, 53-7179-42, Invitrogen Antibodies. Intracellular staining of normal human peripheral blood cells stimulated overnight with PMA/Ionomycin in the presence of monensin with Anti-Human CD3 APC (Product # 17-0038-42) and Mouse IgG1 K Isotype Control Alexa Fluor® 488 (Product # 53-4714-42) (left) or Anti-Human IL-17A Alexa Fluor® 488 (right) using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00). Cells in the lymphocyte gate were used for analysis.

Mouse Mono [eBio64DEC17], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 61-7179-41

IL-17 antibody, 61-7179-41, Invitrogen Antibodies. Normal human peripheral blood lymphocytes were stimulated with Cell Stimulation Cocktail (Product # 00-4975-03) in the presence of Protein Transport Inhibitor Cocktail (Product # 00-4980-03). Cells were fixed and stained intracellularly with Anti-Human CD4 APC (Product # 17-0049-42) and Mouse IgG1 K Isotype Control PE-eFluor® 610 (Product # 61-4714-82) (left) or Anti-Human IL-17A PE-eFluor® 610 (right) using the Fixation and Permeabilization Buffers set (Product # 88-8824-00). Viable cel

Mouse Mono [eBio64DEC17], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 12-7178-42

IL-17 antibody, 12-7178-42, Invitrogen Antibodies. Normal human peripheral blood cells were stimulated overnight with PMA and Ionomycin in the presence of monensin. Cells were stained with Anti-Human CD3 FITC (Product # 11-0037-42), then fixed, permeablized, and stained with Anti-Human IL-17A PE (Left figure). The ligand blocking control demonstrates that pre-blocking Anti-Human IL-17A PE with 1.0 µg of Human IL-17A Recombinant Protein (Product # 14-8179-80) prior to staining abrogates specific IL-17A staining (Right figure). Cells in the

Mouse Mono [eBio64CAP17], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 12-7179-41

IL-17 antibody, 12-7179-41, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 10 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 6 hours. Cells were intracellular stained with Anti-Human CD4 APC (Product # 17-0049-42) and Anti-Human IL-17A FITC using the Fixation & Permeabilizati

Mouse Mono [eBio64DEC17], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 50-7179-41

IL-17 antibody, 50-7179-41, Invitrogen Antibodies. Intracellular staining of normal human peripheral blood cells stimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) for 5 hours with Anti-Human CD3 FITC (Product # 11-0037-42) and Mouse IgG1 K Isotype Control eFluor® 660 (Product # 50-4714-82) (left) or Anti-Human IL-17A eFluor® 660 (right). Cells were fixed and permeabilized using Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00). Cells in the lymphocyte gat

Mouse Mono [eBio64DEC17], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 48-7179-41

IL-17 antibody, 48-7179-41, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 6 days. Cells were restimulated with the Cell Stimulation Cocktail plus protein transport inhibitors (Product # 00-4975-03) for 5 hours and then intracellularly stained with Anti-Human CD4 PE (Product # 12-0049-42) and Mouse IgG1 K Isotype Control eFluor® 450 (Product # 12-4714-81) (left) or Anti-Human IL-17A eFluor® 450 (right) using the Intrace

Mouse Mono [eBio64DEC17], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 12-7178-41

IL-17 antibody, 12-7178-41, Invitrogen Antibodies. Normal human peripheral blood cells were stimulated overnight with PMA and Ionomycin in the presence of monensin. Cells were stained with Anti-Human CD3 FITC (Product # 11-0037-42), then fixed, permeablized, and stained with Anti-Human IL-17A PE (Left figure). The ligand blocking control demonstrates that pre-blocking Anti-Human IL-17A PE with 1.0 µg of Human IL-17A Recombinant Protein (Product # 14-8179-80) prior to staining abrogates specific IL-17A staining (Right figure). Cells in the

Mouse Mono [eBio64CAP17], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 11-7177-81

IL-17 antibody, 11-7177-81, Invitrogen Antibodies. Splenocytes were cultured under Th17-polarizing conditions for 6 days and then restimulated with the Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) for 5 hours. Cells were intracellularly stained with Anti-Mouse CD4 PerCP-eFluor® 710 (Product # 46-0042-82) and 0.125 µg of Rat IgG2a K Isotype Control FITC (Product # 11-4321-42) (left) or 0.125 µg of Anti-Mouse/Rat IL-17A FITC (right) using the Intracellular Fixation & Permeabilization Buffer S

Rat Mono [eBio17B7], 50 ug
Mo, Rt
FACS, IHC-P

IHC-P

Supplier data
Invitrogen Antibodies 50-7177-80

IL-17 antibody, 50-7177-80, Invitrogen Antibodies. Mouse splenocytes were cultured for 7 days under Th17-polarization conditions. Cells were unstimulated (left) or stimulated (right) with Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) and intracellularly stained with Anti-Mouse CD4 FITC (Product # 11-0041-82) and 0.125 µg of Anti-Mouse/Rat IL-17A eFluor® 660 using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Viable cells, as determined by Fixable Via

Rat Mono [eBio17B7], 25 ug
Mo, Rt
FACS, IHC-P

IHC-P

Supplier data
Invitrogen Antibodies 48-7177-82

IL-17 antibody, 48-7177-82, Invitrogen Antibodies. Intracellular staining of 10-day Th17-polarized mouse splenocytes stimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.125 µg of Rat IgG2a K Isotype Control (Product # 48-4321-82) (left) or 0.125 µg of Anti-Mouse/Rat IL-17A eFluor® 450 (right) using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Viable cells, as determined by

Rat Mono [eBio17B7], 100 ug
Mo, Rt
FACS

Supplier data
Invitrogen Antibodies 11-7179-41

IL-17 antibody, 11-7179-41, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 10 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 6 hours. Cells were stained Anti-Human CD4 PE (Product # 12-0047-42) and Anti-Human IL-17A FITC using the Fixation & Permeabilization Buffers (Product

Mouse Mono [eBio64DEC17], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 45-7179-42

IL-17 antibody, 45-7179-42, Invitrogen Antibodies. Intracellular staining of normal human peripheral blood cells stimulated with PMA/Ionomycin for 5 hours in the presence of Monensin with Anti-Human CD3 FITC (Product # 11-0039-42) and Mouse IgG1 K Isotype Control PerCP-Cyanine5-5 (Product # 45-4714-82) (left) or Anti-Human IL-17A PerCP-Cyanine5-5 (right). Cells in the lymphocyte gate were used for analysis.

Mouse Mono [eBio64DEC17], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 69-7179-41

IL-17 antibody, 69-7179-41, Invitrogen Antibodies. Normal human peripheral blood cells stimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 5 hours. Cells were intracellularly stained with Anti-Human CD4 PE (Product # 12-0047-42) and Anti-Human IL-17A eFluor® 506, using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Cells in the lymphocyte gate were used for analysis.

Mouse Mono [eBio64DEC17], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 12-7177-81

IL-17 antibody, 12-7177-81, Invitrogen Antibodies. Intracellular staining of 10 day-Th17 polarized mouse splenocytes either unstimulated (left) or stimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) (right) with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.125 µg of Anti-Mouse/Rat IL-17A PE using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Viable cells in the lymphocyte gate were used for analysis.

Rat Mono [eBio17B7], 50 ug
Mo, Rt
FACS

Supplier data
Invitrogen Antibodies 61-7179-42

IL-17 antibody, 61-7179-42, Invitrogen Antibodies. Normal human peripheral blood lymphocytes were stimulated with Cell Stimulation Cocktail (Product # 00-4975-03) in the presence of Protein Transport Inhibitor Cocktail (Product # 00-4980-03). Cells were fixed and stained intracellularly with Anti-Human CD4 APC (Product # 17-0049-42) and Mouse IgG1 K Isotype Control PE-eFluor® 610 (Product # 61-4714-82) (left) or Anti-Human IL-17A PE-eFluor® 610 (right) using the Fixation and Permeabilization Buffers set (Product # 88-8824-00). Viable cel

Mouse Mono [eBio64DEC17], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 47-7179-41

IL-17 antibody, 47-7179-41, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 10 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail plus protein transport inhibitors (Product # 00-4975-03) (right) for 6 hours. Cells were stained intracellularly with Anti-Human CD4 FITC (Product # 11-0047-42) and Anti-Human IL-17A APC-eFluor® 780 using the Intracell

Mouse Mono [eBio64DEC17], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 25-7179-42

IL-17 antibody, 25-7179-42, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 10 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 6 hours. Cells were intracellularly stained with Anti-Human CD4 APC (Product # 17-0049-42) and Anti-Human IL-17A PE-Cyanine7 using the Fixation & Perme

Mouse Mono [eBio64DEC17], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 25-7177-80

IL-17 antibody, 25-7177-80, Invitrogen Antibodies. Intracellular staining of 10-day Th17-polarized mouse splenocytes either unstimulated (left) or stimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) (right) with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.25 µg of Anti-Mouse/Rat IL-17A PE-Cyanine7 using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and protocol.

Rat Mono [eBio17B7], 25 ug
Mo, Rt
FACS

Supplier data
Cell Signaling Technology 13838S IL-17 antibody, 13838S, Cell Signaling Technology.

Rabbit Mono [D1X7L], 100 ul
Ha, Rt
FACS, IP, WB

IP,

IL-17 antibody, 13838S, Cell Signaling Technology, Western Blot image

Supplier data
Cell Signaling Technology 39901S IL-17 antibody, 39901S, Cell Signaling Technology.

Rabbit Mono [39901S], 100 ul
Ha, Rt
FACS

Immunocytochemistry

Supplier data
BioLegend 512325 IL-17 antibody, 512325, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes (in the presence of monensin) were stained with CD3 FITC, fixed, permeabilized and then stained with IL-17A (clone BL168) Brilliant Violet 605™ (top) or mouse IgG1, κ Brilliant Violet 605™ isotype control (bottom).

IL-17 antibody, 512325, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes (in the presence of monensin) were stained with CD3 FITC, fixed, permeabilized and then stained with IL-17A (clone BL168) Brilliant Violet 605™ (top) or mouse IgG1, κ Brilliant Violet 605™ isotype control (bottom).

Mouse Mono [BL168], 25 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 512301 IL-17 antibody, 512301, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with anti-IFN-???

IL-17 antibody, 512301, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with anti-IFN-???

Mouse Mono [BL168], 50 ug
Hu
FACS, ICC

FACS

Supplier data
BioLegend 512304 IL-17 antibody, 512304, BioLegend. PMA (50 ng/ml) + ionomycin (1

Mouse Mono [BL168], 100 Test
Hu
FACS, ICC

FACS

(2)

2 reviews

Supplier data
BioLegend 506908 IL-17 antibody, 506908, BioLegend. PMA+Ionomycin-stimulated mouse thymoma cell line EL-4 intracellular stained with TC11-18H10.1 FITC

IL-17 antibody, 506908, BioLegend. PMA+Ionomycin-stimulated mouse thymoma cell line EL-4 intracellular stained with TC11-18H10.1 FITC

Rat Mono [TC11-18H10.1], 500 ug
Mo
FACS, ICC

FACS

Supplier data
BioLegend 506911 IL-17 antibody, 506911, BioLegend. PMA/ionomycin-stimulated (5 hours) Th17 polarized C57BL/6 mouse CD4+ T cells surface stained with CD4 (GK1.5) PE, then intracellularly stained with TC11-18H10.1 Alexa Fluor® 647

IL-17 antibody, 506911, BioLegend. PMA/ionomycin-stimulated (5 hours) Th17 polarized C57BL/6 mouse CD4+ T cells surface stained with CD4 (GK1.5) PE, then intracellularly stained with TC11-18H10.1 Alexa Fluor® 647

Rat Mono [TC11-18H10.1], 25 ug
Mo
FACS, ICC

FACS

(1)

1 review

Show/hide more from BioLegend

Supplier data
BioLegend 512310 IL-17 antibody, 512310, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with BL168 Alexa Fluor® 647 and CD3 (UCHT1) PE

IL-17 antibody, 512310, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with BL168 Alexa Fluor® 647 and CD3 (UCHT1) PE

Mouse Mono [BL168], 100 Test
Hu
FACS, ICC

FACS

(3)

3 reviews

Supplier data
BioLegend 512318 IL-17 antibody, 512318, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes were intracellular stained with CD4 (RPA-T4) PE and anti-human IL-17A (BL168) Alexa Fluor®700, or blocked with purified BL168 then stained with BL168 Alexa Fluor®700

IL-17 antibody, 512318, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes were intracellular stained with CD4 (RPA-T4) PE and anti-human IL-17A (BL168) Alexa Fluor®700, or blocked with purified BL168 then stained with BL168 Alexa Fluor®700

Mouse Mono [BL168], 100 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 506918 IL-17 antibody, 506918, BioLegend. PMA/ionomycin-stimulated EL-4 cells intracellularly stained with TC11-8H10.1 Pacific Blue™

IL-17 antibody, 506918, BioLegend. PMA/ionomycin-stimulated EL-4 cells intracellularly stained with TC11-8H10.1 Pacific Blue™

Rat Mono [TC11-18H10.1], 100 ug
Mo
FACS, ICC

FACS

Supplier data
BioLegend 512319 IL-17 antibody, 512319, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes surface stained with CD3 FITC and then intracellularly stained with BL168 APC/Cy7 (top) or mouse IgG1, κ APC/Cy7 isotype control (bottom)

IL-17 antibody, 512319, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes surface stained with CD3 FITC and then intracellularly stained with BL168 APC/Cy7 (top) or mouse IgG1, κ APC/Cy7 isotype control (bottom)

Mouse Mono [BL168], 25 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 512312 IL-17 antibody, 512312, BioLegend.

Mouse Mono [BL168], 100 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 506920 IL-17 antibody, 506920, BioLegend. PMA/Ionomycin stimulated (6 hours) EL-4 cells stained with TC11-18H10.1 PerCP/Cy5.5

Rat Mono [TC11-18H10.1], 100 ug
Mo
FACS, ICC

FACS

Supplier data
BioLegend 506929 IL-17 antibody, 506929, BioLegend. Th17-polarized C57BL/6 mouse CD4+ lymphocytes were stimulated with PMA + Ionomycin for 6 hours (in the presence of monensin), stained with CD4 FITC, fixed, permeabilized, and then stained with IL-17A (clone TC11-18H10.1) Brilliant Violet 650™.

IL-17 antibody, 506929, BioLegend. Th17-polarized C57BL/6 mouse CD4+ lymphocytes were stimulated with PMA + Ionomycin for 6 hours (in the presence of monensin), stained with CD4 FITC, fixed, permeabilized, and then stained with IL-17A (clone TC11-18H10.1) Brilliant Violet 650™.

Rat Mono [TC11-18H10.1], 125 ul
Mo
FACS, ICC

FACS

Supplier data
BioLegend 512313 IL-17 antibody, 512313, BioLegend. PMA+ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellularly stained with BL168 PerCP/Cy5.5 and CD3 (UCHT1) APC

IL-17 antibody, 512313, BioLegend. PMA+ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellularly stained with BL168 PerCP/Cy5.5 and CD3 (UCHT1) APC

Mouse Mono [BL168], 25 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 512317 IL-17 antibody, 512317, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes were intracellular stained with CD4 (RPA-T4) PE and anti-human IL-17A (BL168) Alexa Fluor®700, or blocked with purified BL168 then stained with BL168 Alexa Fluor®700

IL-17 antibody, 512317, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes were intracellular stained with CD4 (RPA-T4) PE and anti-human IL-17A (BL168) Alexa Fluor®700, or blocked with purified BL168 then stained with BL168 Alexa Fluor®700

Mouse Mono [BL168], 25 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 512306 IL-17 antibody, 512306, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with CD3 (UCHT1) APC and anti-human IL-17A (BL168) PE

IL-17 antibody, 512306, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with CD3 (UCHT1) APC and anti-human IL-17A (BL168) PE

Mouse Mono [BL168], 100 Test
Hu
FACS, ICC

FACS

(1)

1 review

Supplier data
BioLegend 506914 IL-17 antibody, 506914, BioLegend. 6 hours PMA (20 ng/ml) + ionomycin (1

Rat Mono [TC11-18H10.1], 100 ug
Mo
FACS, ICC

FACS

Supplier data
BioLegend 512311 IL-17 antibody, 512311, BioLegend.

Mouse Mono [BL168], 25 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 506904 IL-17 antibody, 506904, BioLegend. PMA/ionomycin-stimulated (5 hours) Th17 polarized C57BL/6 mouse CD4+ T cells surface stained with CD4 (GK1.5) APC, then intracellularly stained with TC11-18H10.1 PE

IL-17 antibody, 506904, BioLegend. PMA/ionomycin-stimulated (5 hours) Th17 polarized C57BL/6 mouse CD4+ T cells surface stained with CD4 (GK1.5) APC, then intracellularly stained with TC11-18H10.1 PE

Rat Mono [TC11-18H10.1], 100 ug
Mo
FACS, ICC

FACS

(1)

1 review

Supplier data
BioLegend 506916 IL-17 antibody, 506916, BioLegend. PMA/Ionomycin stimulatd (6 hrs) EL-4 cells stained with TC11-18H10.1 APC

Rat Mono [TC11-18H10.1], 100 ug
Mo
FACS, ICC

FACS

Supplier data
BioLegend 512309 IL-17 antibody, 512309, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with BL168 Alexa Fluor® 647 and CD3 (UCHT1) PE

IL-17 antibody, 512309, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with BL168 Alexa Fluor® 647 and CD3 (UCHT1) PE

Mouse Mono [BL168], 25 Test
Hu
FACS, ICC

FACS

(1)

1 review

Supplier data
BioLegend 506925 IL-17 antibody, 506925, BioLegend. Th17-polarized C57BL/6 mouse CD4+ lymphocytes were stimulated with PMA + Ionomycin for 6 hours in the presence of monensin, stained with CD4 FITC, fixed, permeabilized, and then stained with IL-17A (clone TC11-18H10.1) Brilliant Violet 421™ (top) or rat IgG1, κ Brilliant Violet 421™ isotype control (bottom).

IL-17 antibody, 506925, BioLegend. Th17-polarized C57BL/6 mouse CD4+ lymphocytes were stimulated with PMA + Ionomycin for 6 hours in the presence of monensin, stained with CD4 FITC, fixed, permeabilized, and then stained with IL-17A (clone TC11-18H10.1) Brilliant Violet 421™ (top) or rat IgG1, κ Brilliant Violet 421™ isotype control (bottom).

Rat Mono [TC11-18H10.1], 125 ul
Mo
FACS, ICC

FACS

Supplier data
BioLegend 512327 IL-17 antibody, 512327, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes (in the presence of monensin) were surface stained with CD3 FITC, fixed, permeabilized and then stained with IL-17A (clone BL168) Brilliant Violet 711™ (top) or mouse IgG1, κ Brilliant Violet 711™ isotype control (bottom).

IL-17 antibody, 512327, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes (in the presence of monensin) were surface stained with CD3 FITC, fixed, permeabilized and then stained with IL-17A (clone BL168) Brilliant Violet 711™ (top) or mouse IgG1, κ Brilliant Violet 711™ isotype control (bottom).

Mouse Mono [BL168], 25 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 506921 IL-17 antibody, 506921, BioLegend. PMA/ionomycin-stimulated (6 hours) EL-4 cells stained with TC11-18H10.1 PE/Cy7

Rat Mono [TC11-18H10.1], 25 ug
Mo
FACS, ICC

FACS

Supplier data
BioLegend 506910 IL-17 antibody, 506910, BioLegend. PMA+Ionomycin-stimulated mouse thymoma cell line EL-4 intracellular stained with TC11-18H10.1 Alexa Fluor® 488

IL-17 antibody, 506910, BioLegend. PMA+Ionomycin-stimulated mouse thymoma cell line EL-4 intracellular stained with TC11-18H10.1 Alexa Fluor® 488

Rat Mono [TC11-18H10.1], 100 ug
Mo
FACS, ICC

FACS

(5)

5 reviews

Supplier data
BioLegend 506919 IL-17 antibody, 506919, BioLegend. PMA/Ionomycin stimulated (6 hours) EL-4 cells stained with TC11-18H10.1 PerCP/Cy5.5

Rat Mono [TC11-18H10.1], 25 ug
Mo
FACS, ICC

FACS

Supplier data
BioLegend 506903 IL-17 antibody, 506903, BioLegend. PMA/ionomycin-stimulated (5 hours) Th17 polarized C57BL/6 mouse CD4+ T cells surface stained with CD4 (GK1.5) APC, then intracellularly stained with TC11-18H10.1 PE

IL-17 antibody, 506903, BioLegend. PMA/ionomycin-stimulated (5 hours) Th17 polarized C57BL/6 mouse CD4+ T cells surface stained with CD4 (GK1.5) APC, then intracellularly stained with TC11-18H10.1 PE

Rat Mono [TC11-18H10.1], 25 ug
Mo
FACS, ICC

FACS

(1)

1 review

Supplier data
BioLegend 512302 IL-17 antibody, 512302, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with anti-IFN-???

IL-17 antibody, 512302, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with anti-IFN-???

Mouse Mono [BL168], 500 ug
Hu
FACS, ICC

FACS

Supplier data
BioLegend 512323 IL-17 antibody, 512323, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes (in the presence of monensin) were intracellularly stained with CD3 APC and anti-IL-17A (clone BL168) Brilliant Violet 570™ (top) or mouse IgG1, κ Brilliant Violet 570™ isotype control (bottom).

IL-17 antibody, 512323, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes (in the presence of monensin) were intracellularly stained with CD3 APC and anti-IL-17A (clone BL168) Brilliant Violet 570™ (top) or mouse IgG1, κ Brilliant Violet 570™ isotype control (bottom).

Mouse Mono [BL168], 25 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 512320 IL-17 antibody, 512320, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes surface stained with CD3 FITC and then intracellularly stained with BL168 APC/Cy7 (top) or mouse IgG1, κ APC/Cy7 isotype control (bottom)

IL-17 antibody, 512320, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes surface stained with CD3 FITC and then intracellularly stained with BL168 APC/Cy7 (top) or mouse IgG1, κ APC/Cy7 isotype control (bottom)

Mouse Mono [BL168], 100 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 512321 IL-17 antibody, 512321, BioLegend. Human peripheral blood lymphocytes were stimulated with PMA + Ionomycin for 6 hours in presence of monensin, stained with CD3-FITC, fixed, and permeabilized, then stained with IL-17A (clone BL168) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).

IL-17 antibody, 512321, BioLegend. Human peripheral blood lymphocytes were stimulated with PMA + Ionomycin for 6 hours in presence of monensin, stained with CD3-FITC, fixed, and permeabilized, then stained with IL-17A (clone BL168) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).

Mouse Mono [BL168], 25 Test
Hu
FACS, ICC

FACS

(1)

1 review

Supplier data
BioLegend 506922 IL-17 antibody, 506922, BioLegend. PMA/ionomycin-stimulated (6 hours) EL-4 cells stained with TC11-18H10.1 PE/Cy7

Rat Mono [TC11-18H10.1], 100 ug
Mo
FACS, ICC

FACS

Supplier data
BioLegend 512322 IL-17 antibody, 512322, BioLegend. Human peripheral blood lymphocytes were stimulated with PMA + Ionomycin for 6 hours in presence of monensin, stained with CD3-FITC, fixed, and permeabilized, then stained with IL-17A (clone BL168) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).

IL-17 antibody, 512322, BioLegend. Human peripheral blood lymphocytes were stimulated with PMA + Ionomycin for 6 hours in presence of monensin, stained with CD3-FITC, fixed, and permeabilized, then stained with IL-17A (clone BL168) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).

Mouse Mono [BL168], 100 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 506917 IL-17 antibody, 506917, BioLegend. PMA/ionomycin-stimulated EL-4 cells intracellularly stained with TC11-8H10.1 Pacific Blue™

IL-17 antibody, 506917, BioLegend. PMA/ionomycin-stimulated EL-4 cells intracellularly stained with TC11-8H10.1 Pacific Blue™

Rat Mono [TC11-18H10.1], 25 ug
Mo
FACS, ICC

FACS

(1)

1 review

Supplier data
BioLegend 512308 IL-17 antibody, 512308, BioLegend. PMA+ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with BL168 Alexa Fluor(R) 488 and CD3 (UCHT1) PerCP/Cy5.5

IL-17 antibody, 512308, BioLegend. PMA+ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with BL168 Alexa Fluor(R) 488 and CD3 (UCHT1) PerCP/Cy5.5

Mouse Mono [BL168], 100 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 512305 IL-17 antibody, 512305, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with CD3 (UCHT1) APC and anti-human IL-17A (BL168) PE

IL-17 antibody, 512305, BioLegend. PMA + ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with CD3 (UCHT1) APC and anti-human IL-17A (BL168) PE

Mouse Mono [BL168], 25 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 506907 IL-17 antibody, 506907, BioLegend. PMA+Ionomycin-stimulated mouse thymoma cell line EL-4 intracellular stained with TC11-18H10.1 FITC

IL-17 antibody, 506907, BioLegend. PMA+Ionomycin-stimulated mouse thymoma cell line EL-4 intracellular stained with TC11-18H10.1 FITC

Rat Mono [TC11-18H10.1], 50 ug
Mo
FACS, ICC

FACS

(1)

1 review

Supplier data
BioLegend 512303 IL-17 antibody, 512303, BioLegend. PMA (50 ng/ml) + ionomycin (1

Mouse Mono [BL168], 25 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 512315 IL-17 antibody, 512315, BioLegend. PMA/ionomycin-stimulated (5 hours) human peripheral blood lymphocytes intracellularly stained with BL168 PE/Cy7 and CD4 (RPA-T4) PE

IL-17 antibody, 512315, BioLegend. PMA/ionomycin-stimulated (5 hours) human peripheral blood lymphocytes intracellularly stained with BL168 PE/Cy7 and CD4 (RPA-T4) PE

Mouse Mono [BL168], 25 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 512314 IL-17 antibody, 512314, BioLegend. PMA+ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellularly stained with BL168 PerCP/Cy5.5 and CD3 (UCHT1) APC

IL-17 antibody, 512314, BioLegend. PMA+ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellularly stained with BL168 PerCP/Cy5.5 and CD3 (UCHT1) APC

Mouse Mono [BL168], 100 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 506915 IL-17 antibody, 506915, BioLegend. PMA/Ionomycin stimulatd (6 hrs) EL-4 cells stained with TC11-18H10.1 APC

Rat Mono [TC11-18H10.1], 25 ug
Mo
FACS, ICC

FACS

Supplier data
BioLegend 506912 IL-17 antibody, 506912, BioLegend. PMA/ionomycin-stimulated (5 hours) Th17 polarized C57BL/6 mouse CD4+ T cells surface stained with CD4 (GK1.5) PE, then intracellularly stained with TC11-18H10.1 Alexa Fluor® 647

IL-17 antibody, 506912, BioLegend. PMA/ionomycin-stimulated (5 hours) Th17 polarized C57BL/6 mouse CD4+ T cells surface stained with CD4 (GK1.5) PE, then intracellularly stained with TC11-18H10.1 Alexa Fluor® 647

Rat Mono [TC11-18H10.1], 100 ug
Mo
FACS, ICC

FACS

(1)

1 review

Supplier data
BioLegend 512307 IL-17 antibody, 512307, BioLegend. PMA+ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with BL168 Alexa Fluor(R) 488 and CD3 (UCHT1) PerCP/Cy5.5

IL-17 antibody, 512307, BioLegend. PMA+ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellular stained with BL168 Alexa Fluor(R) 488 and CD3 (UCHT1) PerCP/Cy5.5

Mouse Mono [BL168], 25 Test
Hu
FACS, ICC

FACS

Supplier data
BioLegend 506909 IL-17 antibody, 506909, BioLegend. PMA+Ionomycin-stimulated mouse thymoma cell line EL-4 intracellular stained with TC11-18H10.1 Alexa Fluor® 488

IL-17 antibody, 506909, BioLegend. PMA+Ionomycin-stimulated mouse thymoma cell line EL-4 intracellular stained with TC11-18H10.1 Alexa Fluor® 488

Rat Mono [TC11-18H10.1], 25 ug
Mo
FACS, ICC

FACS

Related antibodies

IL-17 antibodies are often published with	Associated citations
IL-12	15.0%
IL-4	14.8%
CD3	12.4%
IL-6	9.2%
PMP-22	8.4%
CD25	7.9%
FOXP3	7.9%
CD28	6.4%
CD8	6.0%
CD11b	5.7%

Bac	Bacteria
Bt	Bat
Bv	Bovine
Cel	C.Elegans
Cml	Camel
Cn	Canine
chem	Chemical
Ch	Chicken
Dk	Donkey
Dr	Drosophila
Du	Duck
Eq	Equine
Eu	Eukaryotes
Fe	Feline
Fi	Fish
Fr	Frog
Fu	Fungus
Gt	Goat
Gf	Goldfish
GP	Guinea Pig
Ha	Hamster
Hu	Human
Inv	Invertebrates
Llm	Llama
Mam	Mammals
Mo	Mouse
Pl	Plant
Po	Porcine
Pr	Primate
Pro	Prokaryotes
Rb	Rabbit
Rt	Rat
Sh	Sheep
Sq	Squirrel
Vert	Vertebrates
Vi	Virus
Xe	Xenopus
Yt	Yeast
Zf	Zebrafish

AP	Affinity purification
Bl	Blocking
ChIP	Chromatin Immunoprecipitation
DB	Dot Blot
EMSA	Electron Microscopy
ELISA	Enzyme Linked Immunosorbent Assay
FACS	Flow Cytometry
FA	Functional Assay
GS	Gel Shift
ICC	Immunocytochemistry
ID	Immunodiffusion
IF	Immunofluorescence
IHC-F	Immunohistochemistry frozen
IHC-P	Immunohistochemistry paraffin
IP	Immunoprecipitation
IVT	In vivo targeting
Neu	Neutralising
Pep-ELISA	Peptide ELISA
PLA	Proximity Ligation Assay
RIA	Radioimmunoassay
WB	Western Blot

589 matching IL-17 monoclonal antibodies from 25 suppliers

Superstar Kits

IL-17 information

Aliases

12 Applications, 12 Species currently selected